[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fJ3hrox36OP7aPF_N1HVpC8JVAoNItgIVVjcKm2c2fTY":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":32,"type":33},[],"2023-11-30 12:19:59",110118718,[8,9,10,11,12],"无重复用药史,基本可排除合并用药导致的可能性","有文献资料佐证","用药及反应发生时间顺序合理","排除原患疾病等其他混杂因素影响","停药后反应停止,再次使用反应再现,并明显加重",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},21,"13a04c1538a7fcf9540d4a9ea124c4a3","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F721b7e32c462c94f0ce6ed9a34f0c126.jpg","临床药物治疗学","956079023d704c829bdbc69b062d2b02","4药物不良放应","ADR因果关系评定为"很可能"的依据中,与"肯定"的依据不同的是",[22,34,44,54,64,73,82,90,100,108],{"answer":23,"createTime":5,"id":24,"options":25,"question":31,"source":32,"type":33},[],110118709,[26,27,28,29,30],"大剂量下出现的不良反应","血药浓度已降至阈浓度以下,仍残存的生物效应","治疗剂量下出现的不良反应","仅发生于个别人的不良反应","突然停药后,原有疾病再次出现并加剧","后遗效应是指","v1",0,{"answer":35,"createTime":5,"id":36,"options":37,"question":43,"source":32,"type":33},[],110118710,[38,39,40,41,42],"治疗量","极量","中毒量","LD50","以上都有可能","可能产生不良反应的剂量是",{"answer":45,"createTime":5,"id":46,"options":47,"question":53,"source":32,"type":33},[],110118711,[48,49,50,51,52],"有合理的时间关系","撤药后不良反应症状消除","再次使用再次出现同样反应","有其他原因或混杂因素干扰","有所用药物ADR的报道和评述","以下"ADR因果关系评价肯定的依据"中,不正确的是",{"answer":55,"createTime":5,"id":56,"options":57,"question":63,"source":32,"type":33},[],110118712,[58,59,60,61,62],"人员联系","不良反应症状消除","发生事件后撤药的结果","是否有其他原因或混杂因素存在","是否已有对所用药物ADR的报道和评述","以下有关"ADR因果关系评价原则"的叙述中,不正确的是",{"answer":65,"createTime":5,"id":66,"options":67,"question":72,"source":32,"type":33},[],110118713,[68,69,70,71],"特异质反应","变态反应","后遗反应","三致反应","少数病人的特异性遗传素质使机体产生的异常药物反应称为",{"answer":74,"createTime":5,"id":75,"options":76,"question":81,"source":32,"type":33},[],110118714,[77,78,79,80],"与药物作用无关","潜伏期长","不具重现性","与药物剂量有关","下列属于A型不良反应特点的是",{"answer":83,"createTime":5,"id":84,"options":85,"question":89,"source":32,"type":33},[],110118715,[86,80,87,88],"较为常见","病死率高","可通过减量或停药避免","下列属于B型不良反应特点的是",{"answer":91,"createTime":5,"id":92,"options":93,"question":99,"source":32,"type":33},[],110118716,[94,95,96,97,98],"弥补药品上市前研究的不足","减少ADR的危害","促进临床合理用药","促进新药的研制开发","简化或缩短新药临床试验","对于药物不良反应监测的目的和意义的叙述中,错误的是",{"answer":101,"createTime":5,"id":102,"options":103,"question":107,"source":32,"type":33},[],110118717,[9,104,10,105,106],"停药后反应停止","原患多种疾病混杂因素可能干扰","再次使用反应再现,并明显加重","以下药物不良反应因果关系评定为"肯定"的依据中,错误的是",{"answer":109,"createTime":5,"id":6,"options":110,"question":20,"source":32,"type":33},[],[8,9,10,11,12]]